Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valeria Cento

Showing results (41-50 of 81) with videos related to

Pageof 9
Sort By:
Viruses|June 2, 2021
Frontline Screening for SARS-CoV-2 Infection at Emergency Department Admission by Third Generation Rapid Antigen Test: Can We Spare RT-qPCR?Valeria Cento, Silvia Renica, Elisa Matarazzo, et al.
Plos One|September 1, 2023
Quantitative SARS-CoV-2 subgenomic RNA as a surrogate marker for viral infectivity: Comparison between culture isolation and direct sgRNA quantificationRossana Scutari, Silvia Renica, Valeria Cento, et al.
Nature Communications|January 20, 2021
Genomic epidemiology of SARS-CoV-2 reveals multiple lineages and early spread of SARS-CoV-2 infections in Lombardy, ItalyClaudia Alteri, Valeria Cento, Antonio Piralla, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 8, 2019
HCV resistance compartmentalization within tumoral and non-tumoral liver in transplanted patients with hepatocellular carcinomaMaria C Sorbo, Luca Carioti, Maria C Bellocchi, et al.
Plos One|July 14, 2012
HCV genotypes are differently prone to the development of resistance to linear and macrocyclic protease inhibitorsValeria Cento, Carmen Mirabelli, Romina Salpini, et al.
Antiviral Research|February 26, 2011
HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitroValentina Svicher, Emanuela Balestra, Valeria Cento, et al.
Antimicrobial Resistance and Infection Control|May 11, 2026
Clinical and cost benefit of rapid molecular screening for carbapenem-resistant organisms: a seven-year analysis in a tertiary hospitalRiccardo Bollini, Davide F Bavaro, Francesco De Fazio, et al.
BMC Evolutionary Biology|March 9, 2017
Implications of hepatitis C virus subtype 1a migration patterns for virus genetic sequencing policies in ItalyLize Cuypers, Bram Vrancken, Lavinia Fabeni, et al.
The Journal of Infectious Diseases|January 13, 2012
Study of genotypic and phenotypic HIV-1 dynamics of integrase mutations during raltegravir treatment: a refined analysis by ultra-deep 454 pyrosequencingDaniele Armenia, Ina Vandenbroucke, Lavinia Fabeni, et al.
Diagnostic Microbiology and Infectious Disease|September 15, 2023
An overview of SARS-CoV-2 variants circulating in the 2020-2022 period in LombardyFederica Giardina, Guglielmo Ferrari, Federica Zavaglio, et al.
Pageof 9

Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
Viruses|June 2, 2021
Frontline Screening for SARS-CoV-2 Infection at Emergency Department Admission by Third Generation Rapid Antigen Test: Can We Spare RT-qPCR?Valeria Cento, Silvia Renica, Elisa Matarazzo, et al.
Plos One|September 1, 2023
Quantitative SARS-CoV-2 subgenomic RNA as a surrogate marker for viral infectivity: Comparison between culture isolation and direct sgRNA quantificationRossana Scutari, Silvia Renica, Valeria Cento, et al.
Nature Communications|January 20, 2021
Genomic epidemiology of SARS-CoV-2 reveals multiple lineages and early spread of SARS-CoV-2 infections in Lombardy, ItalyClaudia Alteri, Valeria Cento, Antonio Piralla, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 8, 2019
HCV resistance compartmentalization within tumoral and non-tumoral liver in transplanted patients with hepatocellular carcinomaMaria C Sorbo, Luca Carioti, Maria C Bellocchi, et al.
Plos One|July 14, 2012
HCV genotypes are differently prone to the development of resistance to linear and macrocyclic protease inhibitorsValeria Cento, Carmen Mirabelli, Romina Salpini, et al.
Antiviral Research|February 26, 2011
HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitroValentina Svicher, Emanuela Balestra, Valeria Cento, et al.
Antimicrobial Resistance and Infection Control|May 11, 2026
Clinical and cost benefit of rapid molecular screening for carbapenem-resistant organisms: a seven-year analysis in a tertiary hospitalRiccardo Bollini, Davide F Bavaro, Francesco De Fazio, et al.
BMC Evolutionary Biology|March 9, 2017
Implications of hepatitis C virus subtype 1a migration patterns for virus genetic sequencing policies in ItalyLize Cuypers, Bram Vrancken, Lavinia Fabeni, et al.
The Journal of Infectious Diseases|January 13, 2012
Study of genotypic and phenotypic HIV-1 dynamics of integrase mutations during raltegravir treatment: a refined analysis by ultra-deep 454 pyrosequencingDaniele Armenia, Ina Vandenbroucke, Lavinia Fabeni, et al.
Diagnostic Microbiology and Infectious Disease|September 15, 2023
An overview of SARS-CoV-2 variants circulating in the 2020-2022 period in LombardyFederica Giardina, Guglielmo Ferrari, Federica Zavaglio, et al.
Pageof 9